Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Experimental & Clinical Cancer Research : CR|October 2, 2021
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinationsVincent Lemaire, Colby S Shemesh, Anand Rotte
Pharmaceutical Research|November 20, 2014
Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancerColby S Shemesh, Delaram Moshkelani, Hailing Zhang
Pharmaceutical Research|March 28, 2012
Near-infrared image-guided delivery and controlled release using optimized thermosensitive liposomesDavid C Turner, Delaram Moshkelani, Colby S Shemesh, et al.
Photodiagnosis and Photodynamic Therapy|March 25, 2014
Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cellsColby S Shemesh, Claire W Hardy, David S Yu, et al.
Clinical and Translational Science|October 13, 2023
Applying Natural Language Processing to ClinicalTrials.gov: mRNA cancer vaccine case studyBianca Vora, Denison Kuruvilla, Chloe Kim, et al.
Liver Cancer|November 1, 2021
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic RegionColby S Shemesh, Phyllis Chan, Hui Shao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2020
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and OpportunitiesColby S Shemesh, Joy C Hsu, Iraj Hosseini, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2024
Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumorsColby S Shemesh, Yongsheng Wang, Andrew An, et al.
Clinical Pharmacology and Therapeutics|May 22, 2023
Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling FrameworkColby S Shemesh, Phyllis Chan, Mathilde Marchand, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2020
Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphomaColby S Shemesh, Priya Agarwal, Tong Lu, et al.
Pageof 3